The vast majority of GLP-1 side effects — nausea, constipation, diarrhea, reduced appetite — are unpleasant but not dangerous. They make the first few weeks uncomfortable, and then they improve. But GLP-1 medications also carry rare but serious risks that every patient should understand before starting treatment.
This guide is not meant to scare you away from GLP-1s. These medications have strong safety profiles supported by extensive clinical trial data. But informed patients know what to watch for and when to act. Here is your reference guide to the serious side effects that warrant medical attention.
Pancreatitis: The Most Important Warning
Acute pancreatitis is the most clinically significant rare side effect of GLP-1 medications. It occurs in approximately 0.1–0.4% of patients across clinical trials — rare, but not negligible when millions of people are taking these drugs.
Warning Signs
- Severe abdominal pain that starts suddenly and is persistent (not crampy or intermittent)
- Pain that radiates from the upper abdomen to the back
- Pain that worsens after eating, especially fatty foods
- Nausea and vomiting that are more severe than your typical GLP-1 nausea — think projectile vomiting or inability to keep any fluids down
- Fever accompanying abdominal pain
- Rapid heart rate with abdominal pain
What to Do
Stop the medication and go to the emergency room. Pancreatitis is diagnosed with blood tests (lipase and amylase levels) and imaging (CT scan or ultrasound). Early diagnosis and treatment dramatically improve outcomes. Do not take another dose of your GLP-1 until you have been evaluated.
Risk Factors
- History of pancreatitis (including gallstone-related)
- Heavy alcohol use
- Very high triglyceride levels (>500 mg/dL)
- Gallstones (which can trigger pancreatitis independently)
If you have any of these risk factors, discuss them with your prescriber before starting a GLP-1. The risk may still be acceptable, but your monitoring plan should be adjusted.
Thyroid Cancer Concerns (Medullary Thyroid Carcinoma)
All GLP-1 receptor agonists carry a boxed warning about medullary thyroid carcinoma (MTC) based on studies in rodents. In animal studies, semaglutide and other GLP-1 agonists caused thyroid C-cell tumors (MTC) in rats and mice at clinically relevant doses.
The Human Evidence
The direct translation to humans is uncertain. Human thyroid tissue has far fewer GLP-1 receptors on C-cells than rodent thyroid tissue, and observational data from millions of patients on GLP-1s over the past 15+ years has not shown a clear increase in MTC incidence. However, the absolute rarity of MTC (about 2,000 cases/year in the US) makes definitive conclusions difficult.
Warning Signs
- A lump or swelling in the front of your neck
- Difficulty swallowing or a feeling of something stuck in your throat
- Hoarseness or voice changes that are persistent (not from a cold or allergies)
- Shortness of breath related to neck swelling
What to Do
Report any neck lump, persistent hoarseness, or swallowing difficulty to your doctor. They will evaluate with a physical exam, thyroid ultrasound, and potentially a calcitonin blood test (calcitonin is elevated in MTC).
Who Should Not Take GLP-1s
GLP-1 agonists are contraindicated in patients with:
- Personal history of medullary thyroid carcinoma
- Family history of MTC
- Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
If you have a family history of thyroid cancer (any type), discuss this with your prescriber. The contraindication is specific to MTC and MEN 2, not all thyroid cancers.
Gallbladder Disease
Gallbladder problems — including gallstones (cholelithiasis) and inflammation of the gallbladder (cholecystitis) — are a recognized complication of GLP-1 therapy. The incidence in clinical trials is approximately 1–3%, significantly higher than the 0.2–0.5% rate in placebo groups.
The mechanism is straightforward: rapid weight loss increases the concentration of cholesterol in bile, promoting gallstone formation. This risk is not unique to GLP-1s — it applies to any intervention that causes rapid weight loss (bariatric surgery has even higher gallstone rates).
Warning Signs
- Sudden, intense pain in the upper right abdomen (right side, under the rib cage)
- Pain that radiates to the right shoulder or between the shoulder blades
- Pain triggered by eating, especially fatty meals
- Nausea and vomiting accompanying right-sided pain
- Jaundice — yellowing of the skin or whites of the eyes (indicates a gallstone may be blocking the bile duct)
- Fever and chills with abdominal pain (suggests infection/cholecystitis)
What to Do
Right upper quadrant pain with fever or jaundice is a medical emergency. Go to the ER. Gallbladder disease is diagnosed with ultrasound and blood tests (liver function panel, bilirubin). Treatment ranges from observation to cholecystectomy (gallbladder removal surgery) depending on severity.
Prevention
- Avoid crash dieting or extremely low-calorie intake alongside GLP-1 use
- Some studies suggest ursodiol (a bile acid medication) may reduce gallstone risk during rapid weight loss — ask your doctor if you have risk factors
- Maintain adequate fat in your diet (paradoxically, some dietary fat helps the gallbladder contract regularly, preventing bile stasis)
Acute Kidney Injury
GLP-1 medications can cause acute kidney injury (AKI), primarily through dehydration from severe GI side effects. When nausea, vomiting, and diarrhea are severe enough to cause significant fluid loss, kidney function can decline rapidly. The incidence of AKI in clinical trials is approximately 0.1–0.3%.
Warning Signs
- Significantly reduced urine output (much less than usual, or no urine for 8+ hours)
- Very dark urine (dark amber or cola-colored)
- Swelling in the legs, ankles, or around the eyes
- Persistent nausea and vomiting preventing adequate fluid intake for 24+ hours
- Fatigue and confusion beyond what you normally experience
What to Do
If you cannot keep fluids down for more than 24 hours, contact your doctor or go to urgent care. Dehydration-related kidney injury is usually reversible if caught early and treated with IV fluids. Patients with pre-existing chronic kidney disease (CKD) should have more frequent kidney function monitoring while on GLP-1 therapy.
Higher Risk Groups
- Pre-existing chronic kidney disease (stage 3 or higher)
- Patients taking ACE inhibitors, ARBs, or NSAIDs (which affect kidney function)
- Older adults (age 65+)
- Patients with diabetes who also have diabetic kidney disease
Severe Gastroparesis
GLP-1 medications slow gastric emptying — that is part of how they reduce appetite. In most patients, this is mild and manageable. But in rare cases, the slowing is severe enough to constitute gastroparesis, a condition where the stomach fails to empty properly.
Warning Signs
- Persistent, severe nausea and vomiting that does not improve with dose reduction or anti-nausea medication
- Feeling extremely full after eating a very small amount (more than the normal GLP-1 early satiety)
- Vomiting undigested food hours after eating
- Severe bloating and abdominal distension
- Significant unintentional weight loss beyond what is expected from the medication
What to Do
Report persistent severe GI symptoms to your prescriber. Gastroparesis may require discontinuation of the GLP-1 medication. It is usually reversible after stopping the drug, though resolution can take weeks to months. See our GLP-1 gastroparesis and FDA warning update for more detail.
Hypoglycemia (Low Blood Sugar)
GLP-1 medications alone have a low risk of hypoglycemia because their insulin-stimulating effect is glucose-dependent (they stimulate insulin only when blood sugar is elevated). However, hypoglycemia risk increases significantly when GLP-1s are combined with:
- Insulin (any type)
- Sulfonylureas (glipizide, glyburide, glimepiride)
- Meglitinides (repaglinide, nateglinide)
Warning Signs
- Shakiness, sweating, rapid heartbeat
- Dizziness, confusion, irritability
- Blurred vision
- Severe hunger (distinct from the reduced appetite from the GLP-1)
- In severe cases: seizures or loss of consciousness
What to Do
Treat with the "rule of 15": consume 15g of fast-acting carbohydrates (4 glucose tablets, 4 oz juice, or regular soda), wait 15 minutes, and recheck. If you are taking insulin or a sulfonylurea alongside a GLP-1, your doctor may need to reduce the dose of the other medications to prevent hypoglycemia.
Serious Allergic Reactions
Anaphylaxis and severe allergic reactions to GLP-1s are extremely rare (fewer than 1 in 10,000 patients) but have been reported.
Warning Signs
- Swelling of the face, lips, tongue, or throat
- Difficulty breathing or swallowing
- Severe rash or hives
- Rapid heartbeat with a feeling of faintness
What to Do
Call 911 immediately. Do not take another dose. If you have an epinephrine auto-injector (EpiPen), use it.
Suicidal Ideation and Mental Health Effects
In 2023, the FDA and EMA began investigating reports of suicidal ideation in patients taking GLP-1 medications. As of 2026, no causal link has been established in large-scale analyses. The FDA concluded its initial review in early 2024 without adding a warning label. However, monitoring continues.
If you experience new or worsening depression, anxiety, or thoughts of self-harm while taking a GLP-1 medication, contact your doctor immediately. These symptoms warrant evaluation regardless of whether they are drug-related.
Quick Reference: When to Call Your Doctor vs. Go to the ER
| Symptom | Action |
|---|---|
| Mild nausea that improves with dietary changes | Self-manage; mention at next appointment |
| Constipation not responding to OTC treatments after 2 weeks | Call your doctor |
| Cannot keep fluids down for 24+ hours | Call your doctor or go to urgent care |
| Severe upper abdominal pain radiating to back | Go to the ER (possible pancreatitis) |
| Neck lump, persistent hoarseness, difficulty swallowing | Call your doctor within 1–2 days |
| Right upper abdominal pain + fever or jaundice | Go to the ER (possible gallbladder emergency) |
| Very dark urine, minimal output, swelling | Call your doctor same day (possible kidney issue) |
| Severe shakiness, confusion, sweating (hypoglycemia) | Treat immediately; call doctor if recurrent |
| Facial/throat swelling, difficulty breathing | Call 911 (anaphylaxis) |
| New thoughts of self-harm or severe depression | Call doctor or crisis hotline immediately |
Bottom Line
Serious side effects from GLP-1 medications are rare but real. The most important thing you can do is know the warning signs, respond appropriately, and maintain open communication with your prescriber. Most patients will never experience any of these serious effects — but knowing what to watch for is what separates an informed patient from a vulnerable one.
For day-to-day side effect management, see our guide to managing common GLP-1 side effects and our week-by-week side effects timeline.